These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 14631299)

  • 1. [Anti-hepatitis B vaccine: a step towards resolving a conflictive situation?].
    Calès P
    Gastroenterol Clin Biol; 2003 Oct; 27(10):865-7. PubMed ID: 14631299
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B--another vaccine success story.
    Child Health Alert; 2005 Jan; 23():3. PubMed ID: 15799101
    [No Abstract]   [Full Text] [Related]  

  • 3. Positivity rate of hepatitis B surface antigen in 16-year-old first-time blood donors: effectiveness of immunoprophylaxis with hepatitis B vaccine and immunoglobulin in newborn infants with mothers positive for hepatitis B e antigen.
    Uchida S; Tadokoro K
    Jpn J Infect Dis; 2008 Jan; 61(1):94. PubMed ID: 18219148
    [No Abstract]   [Full Text] [Related]  

  • 4. The first identified hepatitis B virus vaccine escape mutation in Turkey.
    Kutlu T; Soycan LY; Karatayli E; Türkyilmaz AR; Yurdaydin C; Bozdayi AM
    J Clin Virol; 2006 Feb; 35(2):201-2. PubMed ID: 16230046
    [No Abstract]   [Full Text] [Related]  

  • 5. [Observation on effects of hepatitis B vaccine immunization for 12 years in children in Beijing].
    Gong XH; Wang FZ; Li H; Liu LR; Li YH; Wang BL; Li LQ; Zhang Z; Han QY; Tang YW
    Zhonghua Yu Fang Yi Xue Za Zhi; 2005 Jul; 39(4):265-8. PubMed ID: 16194384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events after hepatitis A B combination vaccine.
    Woo EJ; Miller NB; Ball R;
    Vaccine; 2006 Mar; 24(14):2685-91. PubMed ID: 16310295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination against hepatitis B and C: towards therapeutic application.
    Inchauspe G; Bach G; Martin P; Bonnefoy JY
    Int Rev Immunol; 2009; 28(1):7-19. PubMed ID: 19241251
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination.
    Lu CY; Chiang BL; Chi WK; Chang MH; Ni YH; Hsu HM; Twu SJ; Su IJ; Huang LM; Lee CY
    Hepatology; 2004 Dec; 40(6):1415-20. PubMed ID: 15565627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study.
    Sapru A; Kulkarni PS; Bhave S; Bavdekar A; Naik SS; Pandit AN
    J Trop Pediatr; 2007 Oct; 53(5):303-7. PubMed ID: 17478542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants.
    Fitzsimons D; François G; Hall A; McMahon B; Meheus A; Zanetti A; Duval B; Jilg W; Böcher WO; Lu SN; Akarca U; Lavanchy D; Goldstein S; Banatvala J; Damme PV
    Vaccine; 2005 Jul; 23(32):4158-66. PubMed ID: 15964484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved immunization practices reduce childhood hepatitis B infection in Tonga.
    Danielsson N; Fakakovikaetau T; Szegedi E
    Vaccine; 2009 Jul; 27(33):4462-7. PubMed ID: 19508908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatitis B virus still under debate].
    Ajana F
    Arch Pediatr; 2006 Sep; 13(9):1269-74. PubMed ID: 16920340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
    Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Viral hepatitis B vaccine prevention and it related problem in China].
    Liu CB; Su CA
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):377-8. PubMed ID: 15231154
    [No Abstract]   [Full Text] [Related]  

  • 16. A low rate of hepatitis B virus vaccine breakthrough infections in Mongolia.
    Ijaz S; Khulan J; Bissett SL; Ferns RB; Nymadawa P; Tedder RS
    J Med Virol; 2006 Dec; 78(12):1554-9. PubMed ID: 17063521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines for neonatal viral infections: hepatitis B vaccine.
    Cutts FT; Hall AJ
    Expert Rev Vaccines; 2004 Aug; 3(4):349-52. PubMed ID: 15270632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
    Connor BA; Blatter MM; Beran J; Zou B; Trofa AF
    J Travel Med; 2007; 14(1):9-15. PubMed ID: 17241248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
    Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
    Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term protection of hepatitis B vaccine 18 years after vaccination.
    Alfaleh F; Alshehri S; Alansari S; Aljeffri M; Almazrou Y; Shaffi A; Abdo AA
    J Infect; 2008 Nov; 57(5):404-9. PubMed ID: 18829116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.